Aggregation, non-specific binding and stability are very protein specific, but a general protocol is given below.
| 1 |
Determine the starting protein concentration (using eg. Expedeon’s BradfordUltra assay, BCA assay, absorbance at 280 nm).
|
| 2 |
Typically a fivefold excess, by mass, of NV10 will protect the target protein. For example, use 100 µg/ml NVoy for 20 µg/ml protein.
|
| 3 |
Each Stabil-P.A.C. tube contains 10mg NV10 as a lyophilised powder (40mg per tube in a Stabil-PAC MAXI).
|
| 4 |
Add the protein solution to NVoy in Stabil-P.A.C. tubes to get the desired concentration, or make up a stock solution (e.g. 5 mg/ml NV10) by adding buffer or distilled water to each Stabil-P.A.C. tube and then add this stock to the protein solution.
|
| 5 |
Dialyse this protein / NVoy solution. |
| 6 |
NVoy associates with the protein in solution and is retained by the membrane during dialysis to give continuing protection further downstream.
|
| 7 |
NV10 stock solutions (up to 10 mg/ml) can be stored for up to 1 week at 4oC or for longer term at -20 oC. More concentrated stock solutions should be used immediately.
|
Troubleshooting
| • |
If the protein shows signs of aggregation or heavy losses the relative NV10 concentration can be increased, ie increase NV10 concentration and / or reduce protein concentration.
|
| • |
Alternatively, a lower NV10 to protein ratio can be used with proteins that have no history of aggregation.
|
| • |
Protein solutions dialysed using membranes with pore sizes of greater than 10,000 kDa may gradually lose NV10 into the dialysis buffer. |